With the launch of Nephron Nitrile, a glove manufacturing venture, Nephron begins a $100 million construction project, adding a new 400,000 square-foot facility to its campus of existing facilities and hiring 250 new workers in the process
Continued combating the scourge of the COVID-19 pandemic by producing testing chemicals known as reagents, as well as the test kits themselves
Partnered with Dominion Energy to open the Nephron Clinical Lab--a way to support Midlands-area residents with fast, reliable COVID-19 vaccination and testing services
Developed a new wing of existing Nephron facilities where manufacturers can focus on the creation of life-saving antibiotics and chemotherapy drugs
Announced a new syringe and equipment manufacturing venture, Inject EZ
Partnered with the ISPE Foundation to launch a new internship program, which aims to diversify Nephron's ever-growing employee base
2020
Progress in a Pandemic
Nephron steps up to respond to COVID-19, seeking FDA approval to ramp up production
Opened a CLIA-certified Diagnostics Lab and began COVID-19 testing for employees, families and businesses in the Midlands and across South Carolina
Launched production of FDA approved hand sanitizer
Broke ground on a historic $215M expansion, including a vaccine production facility
Announced plans for a Kennedy Innovation Complex
Received FDA approval of an Abbreviated New Drug Application (ANDA) for two new products – 0.9% Sodium Chloride IV Bags, and Ketorolac Tromethamine Injection Vials
2019
Innovation
Opened in-house pharmacy for employees and their families
Launched an educator program that employs over 860 local teachers
Reached a total of 2000+ FTE and PTE employees
Added 75,000 square feet of clean room manufacturing space